These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3556412)

  • 1. Androgen administration to transsexual women. II. Hormonal changes.
    Heresová J; Pobisová Z; Hampl R; Stárka L
    Exp Clin Endocrinol; 1986 Dec; 88(2):219-23. PubMed ID: 3556412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of andriol in treatment of androgen deficiency in transsexual women.
    Hampl R; Stárka L; Heresová J; Sípová I; Pobisová Z; Marek J
    J Steroid Biochem; 1986 Jan; 24(1):349-52. PubMed ID: 3702417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the excretion of 3 androgens registered in Czechoslovakia].
    Hampl R; Hána V; Heresová J; Brzek A; Marek J; Stárka L
    Sb Lek; 1989 Jan; 91(1):16-20. PubMed ID: 2717876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of transdermal testosterone or oral dydrogesterone on hypoactive sexual desire disorder in transsexual women: results of a pilot study.
    Kronawitter D; Gooren LJ; Zollver H; Oppelt PG; Beckmann MW; Dittrich R; Mueller A
    Eur J Endocrinol; 2009 Aug; 161(2):363-8. PubMed ID: 19497984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of administering testosterone undecanoate on hormone levels in female transsexuals].
    Stárka L; Hampl R; Heresová J; Sípová I
    Bratisl Lek Listy; 1986 Feb; 85(2):202-8. PubMed ID: 3082467
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females.
    Giltay EJ; Hoogeveen EK; Elbers JM; Gooren LJ; Asscheman H; Stehouwer CD
    J Clin Endocrinol Metab; 1998 Feb; 83(2):550-3. PubMed ID: 9467573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence.
    Wierckx K; Van Caenegem E; Schreiner T; Haraldsen I; Fisher AD; Toye K; Kaufman JM; T'Sjoen G
    J Sex Med; 2014 Aug; 11(8):1999-2011. PubMed ID: 24828032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of three different testosterone formulations in female-to-male transsexual persons.
    Pelusi C; Costantino A; Martelli V; Lambertini M; Bazzocchi A; Ponti F; Battista G; Venturoli S; Meriggiola MC
    J Sex Med; 2014 Dec; 11(12):3002-11. PubMed ID: 25250780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical and hormonal evaluation of transsexual patients: a longitudinal study.
    Meyer WJ; Webb A; Stuart CA; Finkelstein JW; Lawrence B; Walker PA
    Arch Sex Behav; 1986 Apr; 15(2):121-38. PubMed ID: 3013122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contraceptive efficacy of a depot progestin and androgen combination in men.
    Turner L; Conway AJ; Jimenez M; Liu PY; Forbes E; McLachlan RI; Handelsman DJ
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4659-67. PubMed ID: 14557437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals.
    Jacobeit JW; Gooren LJ; Schulte HM
    J Sex Med; 2007 Sep; 4(5):1479-84. PubMed ID: 17635694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term administration of testosterone undecanoate every 3 months for testosterone supplementation in female-to-male transsexuals.
    Mueller A; Kiesewetter F; Binder H; Beckmann MW; Dittrich R
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3470-5. PubMed ID: 17579193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of gonadal androgens and oestrogens on adrenal androgen levels.
    Polderman KH; Gooren LJ; van der Veen EA
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):415-21. PubMed ID: 7586614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex hormone binding globulin: effect of synthetic steroids on the assay and effect of oral contraceptives.
    Bowles SM; Mills RJ
    Ann Clin Biochem; 1981 Jul; 18(Pt 4):226-31. PubMed ID: 7197136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone.
    Gonzalo IT; Swerdloff RS; Nelson AL; Clevenger B; Garcia R; Berman N; Wang C
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3562-72. PubMed ID: 12161475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical and hormonal evaluation of transsexual patients during hormonal therapy.
    Meyer WJ; Finkelstein JW; Stuart CA; Webb A; Smith ER; Payer AF; Walker PA
    Arch Sex Behav; 1981 Aug; 10(4):347-56. PubMed ID: 6794543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of human spermatogenesis by testosterone implants.
    Handelsman DJ; Conway AJ; Boylan LM
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1326-32. PubMed ID: 1430094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hormonal treatment of transsexual persons].
    Tinkanen H; Das P
    Duodecim; 2015; 131(4):372-8. PubMed ID: 26237927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex hormone profiles in oligomenorrheic adolescent girls and the effect of oral contraceptives.
    Siegberg R; Nilsson CG; Stenman UH; Widholm O
    Fertil Steril; 1984 Jun; 41(6):888-93. PubMed ID: 6233177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.